Pharmacyte BiotechPMCB
13F holders, Q1 2026 (March 31)At the end of Q1 2026, 32 institutions reported holding Pharmacyte Biotech Inc. (PMCB) in their 13F filings, up 4 from Q4 2025. 7 opened new positions and 4 sold out. The largest holders were Citadel Advisors ($239K), Geode Capital Management, LLC ($130K) and Renaissance Technologies ($38K). 2 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio) and Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Pharmacyte Biotech Inc.
- CUSIP
- 71715X203
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 7 | $41K |
| Exits | 4 | $73K |
All 13F filers, Q4 2025 → Q1 2026: 293,466 shares bought and 310,021 shares sold, net −16,555 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 32 holders
| Citadel Advisors | 0.00% | Add +56.5% | 359,547 | $239K |
| Geode Capital Management, LLC | 0.00% | Add +58.0% | 195,660 | $130K |
| Renaissance Technologies | 0.00% | Reduce -39.9% | 56,500 | $38K |
| XTX Topco Ltd | 0.00% | Add +114.2% | 52,362 | $35K |
| Vanguard Capital Management LLC | 0.00% | — | 51,467 | $34K |
| Virtu Financial LLC | 0.00% | New | 37,532 | $25K |
| Northern Trust Corp. | 0.00% | No change | 35,601 | $24K |
| Schonfeld Strategic Advisors LLC | 0.00% | Add +3.2% | 27,009 | $18K |
| HRT Financial LP | 0.00% | Reduce -86.5% | 24,741 | $16K |
| Vanguard Fiduciary Trust Co. | 0.00% | — | 23,452 | $16K |
| Equitec Proprietary Markets, LLC | 0.03% | No change | 22,227 | $15K |
| Simplex Trading, LLC | 0.00% | Reduce -22.8% | 19,940 | $13K |
| Two Sigma Securities, LLC | 0.00% | Reduce -33.4% | 16,360 | $11K |
| Jane Street Group, LLC | 0.00% | Add +1.2% | 11,530 | $8K |
| Ground Swell Capital, LLC | 0.02% | New | 11,527 | $8K |
| Commonwealth Equity Services, LLC | 0.00% | New | 10,313 | $7K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -0.2% | 4,889 | $3K |
| UBS Group AG | 0.00% | Add +64.6% | 4,519 | $3K |
| Group One Trading LLC | 0.00% | New | 1,785 | $1K |
| Osaic Holdings, Inc. | 0.00% | Reduce -0.3% | 302 | $200 |
| Sachetta, LLC | 0.00% | No change | 14 | $10 |
| Bfsg, LLC | 0.00% | No change | 5 | $4 |
| Financial Consulate, Inc. | 0.00% | No change | 2 | $2 |
| SBI Securities Co., Ltd. | 0.00% | New | 3 | $2 |
| Morgan Stanley | 0.00% | Reduce -50.0% | 1 | $1 |
| Johnson Financial Group, Inc. | 0.00% | New | 1 | $1 |
| Cwm, LLC | 0.00% | No change | 1 | $1 |
| MCF Advisors LLC | 0.00% | No change | 1 | $1 |
| NewEdge Advisors, LLC | 0.00% | No change | 2 | $1 |
| Abound Wealth Management | 0.00% | New | 1 | $1 |
| BlackRock, Inc. | 0.00% | No change | 1 | $1 |
| Covestor Ltd | 0.00% | No change | 275 | $0 |
"% of holder's portfolio" is PMCB's weight in each manager's 13F, not the share of Pharmacyte Biotech Inc. the manager owns.